ArticleScientific reports2025
Identification and validation of cell senescence genes in recurrent spontaneous abortion via multiple bioinformatics algorithms.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Recurrent spontaneous abortion (RSA) represents a significant challenge in reproductive obstetrics, affecting approximately 5% of couples globally. Despite various treatments, the effectiveness of these interventions remains highly contentious. Emerging evidence suggests that cellular senescence plays a critical role in the pathogenesis of multiple diseases, potentially implicating its involvement in RSA as well. This study integrated two RNA sequencing datasets and employed Weighted Gene Co-Expression Network Analysis (WGCNA) alongside five machine learning algorithms (XGBoost, Boruta, LASSO, SVM-RFE, and Random Forest) to identify cellular senescence genes linked to RSA. Gene expression was validated at both the transcriptome and protein levels using qPCR, Western blot, and immunofluorescence techniques. An Artificial Neural Network (ANN) model was implemented to evaluate their diagnostic value. Additionally, functional enrichment and single-cell RNA sequencing analyses were conducted to investigate the biological functions of these genes. Three cellular senescence genes-TBX2, SRSF3, and TNRC6B-were identified and found to be upregulated in RSA patients. Functional enrichment analysis revealed these genes' involvement in the MAPK signaling pathway, ECM-receptor interaction, and cell-cell communication. Single-cell RNA sequencing demonstrated the distribution of these genes across various cell types, underscoring their significance in RSA. Furthermore, drug sensitivity analysis identified potential small molecule therapeutics for RSA. Cellular senescence may play a central role in the pathology of RSA, with TBX2, SRSF3, and TNRC6B emerging as potential diagnostic biomarkers. This research enhances our understanding of the molecular mechanisms underlying RSA and lays the groundwork for new diagnostic and therapeutic strategies. Nonetheless, further experimental studies are required to elucidate the specific roles and mechanisms of these genes in RSA, with the ultimate goal of achieving precise prevention and personalized treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.